ImmunityBio, Inc. Common Stock vs. Prime Medicine, Inc. Common Stock
IBRX
ImmunityBio, Inc. Common Stock
$10.51 +6.05%
VS PRMEPrime Medicine, Inc. Common Stock
$3.99 +11.45%
ImmunityBio, Inc. Common Stock and Prime Medicine, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| IBRX | PRME | |
|---|---|---|
| Market Cap | $11.14 billion | $723.69 million |
IBRX leads on 1 of 1 size & scale factors.
Dividend
| IBRX | PRME | |
|---|---|---|
| Dividend Yield | — | 80.20% |
IBRX and PRME split the dividend factors evenly.
Risk & Sentiment
| IBRX | PRME | |
|---|---|---|
| Short Interest | 0.42% | 0.00% |
PRME leads on 1 of 1 risk & sentiment factors.
Dig deeper: IBRX overview, IBRX financials, PRME overview, PRME financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.